Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap-mediated sterile inflammation.

Abstract:

:There is emerging evidence that neutrophil extracellular traps (NETs) play important roles in inflammatory processes. Here we report that neutrophils have to be simultaneously activated by integrin-mediated outside-in- and G-protein-coupled receptor (GPCR) signaling to induce NET formation in acute lung injury (ALI), which is associated with a high mortality rate in critically ill patients. NETs consist of decondensed chromatin decorated with granular and cytosolic proteins and they can trap extracellular pathogens. The prerequisite for NET formation is the activation of neutrophils and the release of their DNA. In a neutrophil- and platelet-dependent mouse model of ventilator-induced lung injury (VILI), NETs were found in the lung microvasculature, and circulating NET components increased in the plasma. In this model, blocking integrin-mediated outside-in or either GPCR-signaling or heteromerization of platelet chemokines decreased NET formation and lung injury. Targeting NET components by DNAse1 application or neutrophil elastase-deficient mice protected mice from ALI, whereas DNase1(-/-)/Trap1(m/m) mice had an aggravated ALI, suggesting that NETs directly influence the severity of ALI. These data suggest that NETs form in the lungs during VILI, contribute to the disease process, and thus may be a promising new direction for the treatment of ALI.

journal_name

Blood

journal_title

Blood

authors

Rossaint J,Herter JM,Van Aken H,Napirei M,Döring Y,Weber C,Soehnlein O,Zarbock A

doi

10.1182/blood-2013-07-516484

subject

Has Abstract

pub_date

2014-04-17 00:00:00

pages

2573-84

issue

16

eissn

0006-4971

issn

1528-0020

pii

blood-2013-07-516484

journal_volume

123

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-XL.

    abstract::The induction of tumor cell differentiation represents an attractive strategy for the treatment of a wide range of malignancies. Differentiation of HL-60 promyelocytic leukemia cells towards neutrophils or monocytes has been shown to induce apoptotic cell death, which is inhibited by bcl-2 over-expression. However, th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Benito A,Silva M,Grillot D,Nuñez G,Fernández-Luna JL

    更新日期:1996-05-01 00:00:00

  • A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA.

    abstract::An 81-year-old woman, who presented with sudden episodes of spontaneous bleeding, was found to have a specific inhibitor of factor XIII. Her fibrin clots had approximately 70% gamma-gamma and no alpha polymer formation, under conditions where normal fibrin was fully cross-linked; the patient's clots were soluble in ur...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fukue H,Anderson K,McPhedran P,Clyne L,McDonagh J

    更新日期:1992-01-01 00:00:00

  • Subunit structure of the erythropoietin receptor analyzed by 125I-Epo cross-linking in cells expressing wild-type or mutant receptors.

    abstract::To analyze the structure of the murine erythropoietin receptor (EpoR), wild-type or mutant EpoR cDNAs were expressed in cell lines, and the proteins that cross-linked with 125I-labeled erythropoietin (Epo) were analyzed by immunoprecipitation using an antibody against the intracellular region of the cloned EpoR. COS-7...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Miura O,Ihle JN

    更新日期:1993-04-01 00:00:00

  • Acute graft-versus-host disease: a bench-to-bedside update.

    abstract::Over the past 5 years, many novel approaches to early diagnosis, prevention, and treatment of acute graft-versus-host disease (aGVHD) have been translated from the bench to the bedside. In this review, we highlight recent discoveries in the context of current aGVHD care. The most significant innovations that have alre...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2014-01-514786

    authors: Holtan SG,Pasquini M,Weisdorf DJ

    更新日期:2014-07-17 00:00:00

  • GATA factor mutations in hematologic disease.

    abstract::GATA family proteins play essential roles in development of many cell types, including hematopoietic, cardiac, and endodermal lineages. The first three factors, GATAs 1, 2, and 3, are essential for normal hematopoiesis, and their mutations are responsible for a variety of blood disorders. Acquired and inherited GATA1 ...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-09-687889

    authors: Crispino JD,Horwitz MS

    更新日期:2017-04-13 00:00:00

  • Neutral tumor evolution in myeloma is associated with poor prognosis.

    abstract::Recent studies suggest that the evolutionary history of a cancer is important in forecasting clinical outlook. To gain insight into the clonal dynamics of multiple myeloma (MM) and its possible influence on patient outcomes, we analyzed whole exome sequencing tumor data for 333 patients from Myeloma XI, a UK phase 3 t...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2016-11-750612

    authors: Johnson DC,Lenive O,Mitchell J,Jackson G,Owen R,Drayson M,Cook G,Jones JR,Pawlyn C,Davies FE,Walker BA,Wardell C,Gregory WM,Cairns D,Morgan GJ,Houlston RS,Kaiser MF

    更新日期:2017-10-05 00:00:00

  • BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells.

    abstract::Chronic lymphocytic leukemia (CLL) patients exhibit a variable clinical course. To investigate the association between clinicobiologic features and responsiveness of CLL cells to anti-IgM stimulation, we evaluated gene expression changes and modifications in cell-cycle distribution, proliferation, and apoptosis of IgV...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-12-127688

    authors: Guarini A,Chiaretti S,Tavolaro S,Maggio R,Peragine N,Citarella F,Ricciardi MR,Santangelo S,Marinelli M,De Propris MS,Messina M,Mauro FR,Del Giudice I,Foà R

    更新日期:2008-08-01 00:00:00

  • Beyond Hox: the role of ParaHox genes in normal and malignant hematopoiesis.

    abstract::During the past decade it was recognized that homeobox gene families such as the clustered Hox genes play pivotal roles both in normal and malignant hematopoiesis. More recently, similar roles have also become apparent for members of the ParaHox gene cluster, evolutionarily closely related to the Hox gene cluster. Thi...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2012-02-385898

    authors: Rawat VP,Humphries RK,Buske C

    更新日期:2012-07-19 00:00:00

  • Deletion of the core region of 5' HS2 of the mouse beta-globin locus control region reveals a distinct effect in comparison with human beta-globin transgenes.

    abstract::The beta-globin locus control region (LCR) is a large DNA element that is required for high-level expression of beta-like globin genes from the endogenous mouse locus or in transgenic mice carrying the human beta-globin locus. The LCR encompasses 6 DNaseI hypersensitive sites (HSs) that bind transcription factors. The...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-06-2308

    authors: Hu X,Bulger M,Bender MA,Fields J,Groudine M,Fiering S

    更新日期:2006-01-15 00:00:00

  • How I conduct a comprehensive chronic graft-versus-host disease assessment.

    abstract::Since the National Institutes of Health Chronic Graft-Versus-Host Disease (cGVHD) Consensus Project in 2005, a need has emerged to evaluate cGVHD more methodically, not only to make a cGVHD diagnosis, but also to accurately classify individual organ and global organ severity, at baseline and in follow-up so that subje...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-04-314815

    authors: Carpenter PA

    更新日期:2011-09-08 00:00:00

  • BVL-1-like VL30 promoter sustains long-term expression in erythroid progenitor cells.

    abstract::Congenital blood disorders are common and yet clinically challenging globin disorders. Gene therapy continues to serve as a potential therapeutic method to treat these disorders. While tremendous advances have been made in vivo, gene delivery protocols and vector prototypes still require optimization. Alternative cis-...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-07-2105

    authors: Staplin WR,Knezetic JA

    更新日期:2003-03-01 00:00:00

  • Hertwig's anemia: characterization of the stem cell defect.

    abstract::Mice homozygous for Hertwig's anemia, an/an, have a mild macrocytic anemia and are refractory to the potentially curative action of exogenously administered erythropoietin (EP). Both red and white blood cell numbers are decreased. One possible explanation is that a precursor stem cell population is in short supply. We...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Barker JE,Bernstein SE

    更新日期:1983-04-01 00:00:00

  • Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves gamma-globin activation by CREB1 and ATF-2.

    abstract::The histone deacetylase inhibitors (HDA-CIs) butyrate and trichostatin A activate gamma-globin expression via a p38 mitogen-activating protein kinase (MAPK)-dependent mechanism. We hypothesized that down-stream effectors of p38 MAPK, namely activating transcription factor-2 (ATF-2) and cyclic AMP response element (CRE...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-01-023713

    authors: Sangerman J,Lee MS,Yao X,Oteng E,Hsiao CH,Li W,Zein S,Ofori-Acquah SF,Pace BS

    更新日期:2006-11-15 00:00:00

  • Soluble CD4, soluble CD8, soluble CD25, lymphopoieitic recovery, and endogenous cytokines after high-dose chemotherapy and blood stem cell transplantation.

    abstract::Mononuclear cell preparations from peripheral blood after mobilization with hematopoietic growth factors have been shown to induce accelerated neutrophil and platelet recovery as compared with that induced by autologous bone marrow transplantation after myeloablative chemotherapy. Because these mononuclear cell produc...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Ho AD,Maruyama M,Maghazachi A,Mason JR,Glück S,Corringham RE

    更新日期:1994-11-15 00:00:00

  • PECAM-1-dependent neutrophil transmigration is independent of monolayer PECAM-1 signaling or localization.

    abstract::Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31), a tyrosine phosphoprotein highly expressed on endothelial cells and leukocytes, is an important component in the regulation of neutrophil transendothelial migration. Engagement of endothelial PECAM-1 activates tyrosine phosphorylation events and evokes prol...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-08-2396

    authors: O'Brien CD,Lim P,Sun J,Albelda SM

    更新日期:2003-04-01 00:00:00

  • Caloric restriction modulates Mcl-1 expression and sensitizes lymphomas to BH3 mimetic in mice.

    abstract::Caloric restriction (CR) is proposed to decrease tumorigenesis through a variety of mechanisms including effects on glycolysis. However, the understanding of how CR affects the response to cancer therapy is still rudimentary. Here, using the Eµ-Myc transgenic mouse model of B-cell lymphoma, we report that by reducing ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-01-478651

    authors: Meynet O,Zunino B,Happo L,Pradelli LA,Chiche J,Jacquin MA,Mondragón L,Tanti JF,Taillan B,Garnier G,Reverso-Meinietti J,Mounier N,Michiels JF,Michalak EM,Carles M,Scott CL,Ricci JE

    更新日期:2013-10-03 00:00:00

  • HOXA9 promotes hematopoietic commitment of human embryonic stem cells.

    abstract::The molecular determinants regulating the specification of human embryonic stem cells (hESCs) into hematopoietic cells remain elusive. HOXA9 plays a relevant role in leukemogenesis and hematopoiesis. It is highly expressed in hematopoietic stem and progenitor cells (HSPCs) and is downregulated upon differentiation. Ho...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-03-558825

    authors: Ramos-Mejía V,Navarro-Montero O,Ayllón V,Bueno C,Romero T,Real PJ,Menendez P

    更新日期:2014-11-13 00:00:00

  • Pim2 cooperates with PML-RARalpha to induce acute myeloid leukemia in a bone marrow transplantation model.

    abstract::Although the potential role of Pim2 as a cooperative oncogene has been well described in lymphoma, its role in leukemia has remained largely unexplored. Here we show that high expression of Pim2 is observed in patients with acute promyelocytic leukemia (APL). To further characterize the cooperative role of Pim2 with p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-210070

    authors: Agrawal-Singh S,Koschmieder S,Gelsing S,Stocking C,Stehling M,Thiede C,Thoennissen NH,Köhler G,Valk PJ,Delwel R,Mills K,Bäumer N,Tickenbrock L,Hansen K,Berdel WE,Müller-Tidow C,Serve H

    更新日期:2010-06-03 00:00:00

  • Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia.

    abstract::Cytofluorimetric detection of the multidrug resistance (MDR)-associated membrane protein (P-170) was performed at the time of diagnosis in 158 patients with acute myeloid leukemia using the C219 monoclonal antibody (MoAb). In 108 of these cases the JSB1 MoAb was also tested. An improved histogram subtraction analysis,...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Del Poeta G,Stasi R,Aronica G,Venditti A,Cox MC,Bruno A,Buccisano F,Masi M,Tribalto M,Amadori S,Papa G

    更新日期:1996-03-01 00:00:00

  • Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.

    abstract::Typical acute promyelocytic leukemia (APL) is associated with expression of the PML-RARalpha fusion protein and responsiveness to treatment with all-trans retinoic acid (ATRA). A rare, but recurrent, APL has been described that does not respond to ATRA treatment and is associated with a variant chromosomal translocati...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Guidez F,Ivins S,Zhu J,Söderström M,Waxman S,Zelent A

    更新日期:1998-04-15 00:00:00

  • An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults.

    abstract::We have used a single intensive chemotherapy regimen in the treatment of young patients with diffuse, aggressive, malignant lymphomas. There were two major histologic types of lymphoma in our series: lymphoblastic lymphomas, which presented most often with mediastinal tumor (64%), and undifferentiated lymphomas (mostl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Magrath IT,Janus C,Edwards BK,Spiegel R,Jaffe ES,Berard CW,Miliauskas J,Morris K,Barnwell R

    更新日期:1984-05-01 00:00:00

  • A new human B-lymphocyte surface antigen (BL 2) detectable by a hybridoma monoclonal antibody: distribution on benign and malignant lymphoid cells.

    abstract::A hybridoma-derived monoclonal antibody, produced by immunization with the Burkitt's tumor-derived B-lymphoblastoid cell line, B35M, was previously shown to detect a 68,000 dalton surface membrane protein, BL2, on the surface of peripheral blood B cells, which is absent from thymocytes, T cells, and granulocytes. In t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Knowles DM 2nd,Tolidjian B,Marboe CC,Halper JP,Azzo W,Wang CY

    更新日期:1983-07-01 00:00:00

  • Thrombopoietin upregulates the promoter conformation of p53 in a proliferation-independent manner coincident with a decreased expression of Bax: potential mechanisms for survival enhancing effects.

    abstract::Thrombopoietin (Tpo) has proliferative and maturational effects on immature and more committed cells, respectively. We previously reported a role for Tpo as a survival factor in the factor-dependent human cell line M07e by demonstrating that Tpo suppresses apoptosis in the absence of induced proliferation. Wild-type p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ritchie A,Gotoh A,Gaddy J,Braun SE,Broxmeyer HE

    更新日期:1997-12-01 00:00:00

  • Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability.

    abstract::The possibility of primitive hematopoietic cell ex vivo expansion is of interest for both gene therapy and transplantation applications. The engraftment of autologous rhesus peripheral blood (PB) progenitors expanded 10 to 14 days were tracked in vivo using genetic marking. Stem cell factor (SCF)/granulocyte colony-st...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tisdale JF,Hanazono Y,Sellers SE,Agricola BA,Metzger ME,Donahue RE,Dunbar CE

    更新日期:1998-08-15 00:00:00

  • Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia.

    abstract::The improved outcome of acquired aplastic anemia (AA) has revealed later complications, such as myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML). We retrospectively analyzed 167 children with severe acquired AA. Eleven of 50 children treated with cyclosporin (CSA) and recombinant human granulocyte c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ohara A,Kojima S,Hamajima N,Tsuchida M,Imashuku S,Ohta S,Sasaki H,Okamura J,Sugita K,Kigasawa H,Kiriyama Y,Akatsuka J,Tsukimoto I

    更新日期:1997-08-01 00:00:00

  • Notch-dependent control of myelopoiesis is regulated by fucosylation.

    abstract::Cell-cell contact-dependent mechanisms that modulate proliferation and/or differentiation in the context of hematopoiesis include mechanisms characteristic of the interactions between members of the Notch family of signal transduction molecules and their ligands. Whereas Notch family members and their ligands clearly ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-11-115204

    authors: Zhou L,Li LW,Yan Q,Petryniak B,Man Y,Su C,Shim J,Chervin S,Lowe JB

    更新日期:2008-07-15 00:00:00

  • The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.

    abstract::The functions of the alphaC domains of fibrinogen in clotting and fibrinolysis, which have long been enigmatic, were determined using recombinant fibrinogen truncated at Aalpha chain residue 251. Scanning electron microscopy and confocal microscopy revealed that the fibers of alpha251 clots were thinner and denser, wi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-05-2150

    authors: Collet JP,Moen JL,Veklich YI,Gorkun OV,Lord ST,Montalescot G,Weisel JW

    更新日期:2005-12-01 00:00:00

  • In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo.

    abstract::Recent findings implied that the progression of hematologic malignancies, like that of solid tumors, is dependent on neovascularization. Recent studies on patients with acute myeloid leukemia (AML) showed increased levels of leukocyte-associated vascular endothelial growth factor (VEGF) and neovascularization of the b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.V100.13.4622

    authors: Schuch G,Machluf M,Bartsch G Jr,Nomi M,Richard H,Atala A,Soker S

    更新日期:2002-12-15 00:00:00

  • Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis.

    abstract::We studied the impact of driver mutations of JAK2, CALR, (calreticulin gene) or MPL on clinical course, leukemic transformation, and survival of patients with primary myelofibrosis (PMF). Of the 617 subjects studied, 399 (64.7%) carried JAK2 (V617F), 140 (22.7%) had a CALR exon 9 indel, 25 (4.0%) carried an MPL (W515)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-05-578435

    authors: Rumi E,Pietra D,Pascutto C,Guglielmelli P,Martínez-Trillos A,Casetti I,Colomer D,Pieri L,Pratcorona M,Rotunno G,Sant'Antonio E,Bellini M,Cavalloni C,Mannarelli C,Milanesi C,Boveri E,Ferretti V,Astori C,Rosti V,Cerva

    更新日期:2014-08-14 00:00:00

  • Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand.

    abstract::X-linked hyper IgM syndrome (XHM) is a combined immune deficiency disorder caused by genetic alterations in CD40 ligand. The purpose of this study was to investigate the safety and efficacy of recombinant CD40 ligand (rCD40L) in the treatment of the disease. Three children were administered rCD40L subcutaneously 3 tim...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2011-04-351254

    authors: Jain A,Kovacs JA,Nelson DL,Migueles SA,Pittaluga S,Fanslow W,Fan X,Wong DW,Massey J,Hornung R,Brown MR,Spinner JJ,Liu S,Davey V,Hill HA,Ochs H,Fleisher TA

    更新日期:2011-10-06 00:00:00